Clinical trial
Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease
NCT03247972 is registered in ClinicalTrials.gov with Inova Health Care Services as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antiplatelet Effects of Evolocumab in Patients With Peripheral Arterial Disease
- Lead sponsor
- Inova Health Care Services
- Phase
- Observational
- Overall status
- Terminated
- Start date
- August 11, 2017
- Completion date
- October 1, 2019
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.